Raphael virus




















GlobalData exists to help businesses decode the future to profit from faster, more informed decisions. Related News Deep Lens announces partnership for clinical trial programme expansion. News I-Mab doses first subject in solid tumour therapy trial in China. News Repligen begins Phase 1 study of RG Last week, admirers of Caravaggio, the Baroque master painter, found themselves locked out of a church in Rome, St. A priest at the church had tested positive for the virus after passing through Italy's north, the heart of the outbreak in Europe.

When the church re-opened on Wednesday, several tourists wore face masks. We'll notify you here with news about. Turn on desktop notifications for breaking stories about interest? It's hoped by the researchers who have spent a year independently testing the spray - created by Raphael Labs, a biotech company created by scientists from universities around the world - that it could either stop or treat the virus, regardless of the strain.

The nasal spray works as a prophylactic rather than a vaccine. The idea is that it is used as a preventative measure against the virus. We've tested it against all the viruses of concern, all the mutations of concern, and it has equal efficacy because it's a chemically-based solution".

Uppal says it's more like a barrier than a vaccine. Connect with the definitive source for global and local news. The Associated Press. All rights reserved.



0コメント

  • 1000 / 1000